IRADIMED CORPORATION IRMD

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$471.09M
Market Cap
$1.10B
Margin of Safety
-133.9%
Intrinsic / Market Ratio
0.43

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

283.27M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

242.14M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

887.85M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

471.09M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

471.09M USD

from the sum above

Market Cap

1.10B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.43×

the ratio the screener ranks by; Margin of Safety -133.9% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 283.27M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)201.60M USD
+②Net Cash Today59.14M USD
+③Growth Value22.53M USD
=Value283.27M USD

EPV of the Operations (NOPAT over WACC)

201.60M USD

Net cash today

+59.14M USD

Growth Value

+22.53M USD

Value

283.27M USD

①EPV (earnings power value)

201.60M USD

②Net Cash Today

59.14M USD

③Growth Value

22.53M USD

Market value

Market Cap1.10B USD

Today's price times the shares.

Value vs market

Margin of Safety-288.9%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 242.14M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE188.05M USD
+②Equity at Year 15, Today54.09M USD
=Value242.14M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

188.05M USD

②Equity at Year 15, Today

54.09M USD

Market value

Market Cap1.10B USD

Today's price times the shares.

Value vs market

Margin of Safety-355.0%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 887.85M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF647.66M USD
+②Invested Capital at Year 15, Today181.05M USD
+③Net Cash Today59.14M USD
=Value887.85M USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

647.66M USD

②Invested Capital at Year 15, Today

181.05M USD

③Net Cash Today

59.14M USD

Market value

Market Cap1.10B USD

Today's price times the shares.

Value vs market

Margin of Safety-24.1%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 9.98%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.91×Market Risk Premium 6.00%= 9.98%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 5.89M USDPretax Income 28.39M USD= 20.74%

The tax the interest saves.

Interest Expense =EBIT 26.17M USD−Pretax Income 28.39M USD= —

The interest the company paid: EBIT is the profit before tax plus the interest.

No interest is read: it needs debt and an EBIT above the profit before tax, the gap between them being the interest. Without it the cost of debt takes the 4% default.

Cost of Debt 4.00% (default): with no debt or no interest read, the 4% default after tax stands for what the lenders are paid a year.

Debt Weight =Total Debt 0 USDMarket Cap + Total Debt 1.10B USD + 0 USD= 0.00%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 100.00%×Cost of Equity 9.98%+Debt Weight 0.00%×Cost of Debt 4.00%= 9.98%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 115.09M USD − Total Liabilities 13.24M USD = Book Value Today 101.85M USD

Total Debt 0 USD − Cash and Short-Term Investments 59.14M USD = Net Debt Today -59.14M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 11.0%at most 5%passes12,786,740 / 12,660,313
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets2.1%at least -10.0%passes(24.97M USD − 22.50M USD) ÷ 115.09M USD
Price to bookMarket Cap ÷ Book Value Today10.82×at most 3×does not pass1.10B USD ÷ 101.85M USD
Operating marginOperating Income ÷ Revenue31.2%above 10.0%passes26.17M USD ÷ 83.90M USD
Revenue growthRevenue ÷ Revenue a Year Before − 114.4%above 10.0%passes83.90M USD / 73.32M USD
Net cash(Cash − Total Debt) ÷ Market Cap5.4%above -30%passes(59.14M USD − 0 USD) ÷ 1.10B USD
Operating efficiencyOperating Income ÷ Gross Profit40.6%above 25.0%passes26.17M USD ÷ 64.39M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

86 USD

Enterprise value

1.06B USD

market cap plus net debt

EV / EBITDA

36.38×

Price / book

10.82×

the provider's book

Price / earnings

48.08×

Return on equity

23.5%

the provider's, not the engine's

Profit margin

26.7%

Revenue growth

0.3%

Analyst target, mean

118 USD

Analysts

2

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

53.36M65.63M73.32M83.90M

Gross profit

41.32M50.21M56.41M64.39M

Operating income

15.64M20.06M21.99M26.17M

EBITDA

operating income before depreciation and amortisation

16.31M20.82M22.81M27.34M

Pretax income

16.20M21.76M24.30M28.39M

Net income

12.84M17.21M19.25M22.50M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

12.86M17.34M19.29M22.34M

R&D

2.28M2.86M2.83M2.98M
Balance sheet, year end

Total assets

85.60M92.25M98.42M108.88M

Total liabilities

11.85M20.76M11.52M14.17M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

73.75M71.49M86.91M94.71M

Total debt

2.21M2.05M2.00K0

Cash and equivalents

58.02M49.81M52.29M51.21M

Net PP&E

fixed assets after depreciation

4.61M11.34M16.83M23.88M

Working capital

current assets less current liabilities

69.00M59.73M66.80M71.09M
Cash flow

Operating cash flow

10.05M13.48M25.65M24.97M

Capital expenditure

paid out, so below zero

-1.88M-8.02M-8.83M-8.43M

Depreciation and amortisation

671.34K765.95K818.82K1.17M

Free cash flow

operating cash flow plus capital expenditure

8.18M5.46M16.82M16.54M